Grindeks

JSC "Grindeks" is a vertically integrated pharmaceutical company based in Riga, the Baltics, with a history dating back to 1946. The company is engaged in the research, development, manufacturing, and sales of original products, generics, and active pharmaceutical ingredients. Grindeks specialises in therapeutic groups concerning heart and cardiovascular, central nervous system (CNS), and anti-cancer medications. Currently, Grindeks produces 23 active pharmaceutical ingredients (APIs), with products exported to 87 countries. The key markets include the EU countries, the U.S.A., Canada, Japan, Russia, other CIS countries, and Vietnam.

Services include:
- Anatomical Therapeutic Chemical (ATC) Classification
- Research and development of pharmaceuticals
- Manufacturing of original products and generics
- Production of active pharmaceutical ingredients (APIs)
- Sales and distribution in international markets

Grindeks continues to be a significant player in the pharmaceutical industry, providing quality products and expertise in various therapeutic areas. For more information, visit grindeks.com.